Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liu, Hanmin
AK0529-2007, NCT06775405: A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants	Recruiting	3	180	RoW	AK0529, Placebo	Shanghai Ark Biopharmaceutical Co., Ltd.	Respiratory Synctial Virus Infections	08/25	09/25
ZX-7101A-210, NCT06669351: Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years with Influenza	Not yet recruiting	3	12	RoW	ZX-7101A	Nanjing Zenshine Pharmaceuticals	Respiratory Viral Infection	08/25	11/25
TNM001-302, NCT06710925: A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants	Not yet recruiting	3	201	RoW	TNM001, placebo	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Respiratory Syncytial Virus Infections	11/27	11/27
NCT06083623: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants	Not yet recruiting	2b	2250	RoW	TNM001, placebo	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Respiratory Syncytial Virus Infections	05/26	08/26
NCT05630573: A Study of TNM001 in Chinese Healthy Preterm and Term Infants	Completed	1/2	31	RoW	TNM001, Placebo	Zhuhai Trinomab Pharmaceutical Co., Ltd.	Respiratory Syncytial Virus Infections	06/23	06/23
NCT05779995: A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV	Recruiting	1/2	60	RoW	XW001, Placebo	Hangzhou Sciwind Biosciences Co., Ltd.	RSV Infection	12/23	05/24